Variation of the antimicrobial susceptibility profiles of Burkholderia cepacia complex clonal isolates obtained from chronically infected cystic fibrosis patients: A five-year survey in the major Portuguese treatment center

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 11, 2008, Pages 1101-1111

  Leitao J H ^a   Sousa, S A ^a   Cunha, M V ^a   Salgado, M J ^b   Melo Cristino, J ^b   Barreto, M C ^b   Sa Correia I ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CEFOTAXIME; CEFRADINE; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA STABILIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; GENOTYPE; HEALTH SURVEY; HUMAN; LUNG FIBROSIS; LUNG INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PORTUGAL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INFANT; MICROBIAL SENSITIVITY TESTS; PNEUMONIA; PORTUGAL; SPUTUM;

EID: 55549117784     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0552-0     Document Type: Article

References (29)

1. E Mahenthiralingam TA Urban JB Goldberg 2005 The multifarious, multireplicon Burkholderia cepacia complex Nat Rev Microbiol 3 144 156
2. JJ LiPuma 2003 Burkholderia and emerging pathogens in cystic fibrosis Semin Respir Crit Care Med 24 681 692
3. DP Speert 2002 Advances in Burkholderia cepacia complex Paediatr Respir Rev 3 230 235
4. FS Collins 1992 Cystic fibrosis: molecular biology and therapeutic implications Science 256 774 779
5. MV Cunha JH Leitão E Mahenthiralingam P Vandamme L Lito C Barreto MJ Salgado I Sá-Correia 2003 Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study J Clin Microbiol 41 4113 4120
6. MV Cunha A Pinto-de-Oliveira L Meirinhos-Soares J Melo-Cristino MJ Salgado S Correia C Barreto I Sá-Correia 2007 Exceptionally high representation of Burkholderia cepacia among B. cepacia complex isolates recovered from the major Portuguese cystic fibrosis center J Clin Microbiol 45 1628 1633
7. A Agodi E Mahenthiralingam M Barchitta V Gianninò A Sciacca S Stefani 2001 Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status J Clin Microbiol 39 2891 2896
8. S Brisse C Cordevant P Vandamme P Bidet C Loukil G Chabanon M Lange E Bingen 2004 Species distribution and ribotype diversity of Burkholderia cepacia complex isolates from French patients with cystic fibrosis J Clin Microbiol 42 4824 4827
9. S Campana G Taccetti N Ravenni F Favari L Cariani A Sciacca D Savoia A Collura E Fiscarelli G De Intinis M Busetti A Cipolloni A d'Aprile E Provenzano I Collebrusco P Frontini G Stassi M Trancassini D Tovagliari A Lavitola CJ Doherty T Coenye JRW Govan P Vandamme 2005 Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy J Clin Microbiol 43 5136 5142
10. JJ LiPuma T Spilker LH Gill PW Campbell 3rd L Liu E Mahenthiralingam 2001 Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis Am J Respir Crit Care Med 164 92 96
11. R Reik T Spilker JJ LiPuma 2005 Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis J Clin Microbiol 43 2926 2928
12. DP Speert D Henry P Vandamme M Corey E Mahenthiralingam 2002 Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada Emerg Infect Dis 8 181 187
13. A Isles I Maclusky M Corey R Gold C Prober P Fleming H Levison 1984 Pseudomonas cepacia infection in cystic fibrosis: an emerging problem J Pediatr 104 206 210
14. S Furukawa SL Kuchma GA O'Toole 2006 Keeping their options open: acute versus persistent infections J Bacteriol 188 1211 1217
15. CA Fux JW Costerton PS Stewart P Stoodley 2005 Survival strategies of infectious biofilms Trends Microbiol 13 34 40
16. A Bevivino C Dalmastri S Tabacchioni L Chiarini ML Belli S Piana A Materazzo P Vandamme G Manno 2002 Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility J Clin Microbiol 40 846 851
17. AN Bauer WMM Kirby JC Sherris M Turck 1966 Antibiotic susceptibility testing by a standardized single disk method Am J Clin Pathol 45 493 496
18. Clinical Laboratory Standards Institute (CLSI) (2005) Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. National Committee for Clinical Laboratory Standards (NCCLS), M100-S15 (vol. 25, no.1)
19. FM Mackenzie SV Smith KE Milne K Griffiths J Legge IM Gould 2004 Antibiograms of resistant Gram-negative bacteria from Scottish CF patients J Cystic Fibrosis 3 151 157
20. TL Pitt ME Kaufmann PS Patel LCA Benge S Gaskin DM Livermore 1996 Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland J Med Microbiol 44 203 210
21. HS Sader RN Jones 2005 Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli Int J Antimicrob Agents 25 95 109
22. J Zhou Y Chen S Tabibi L Alba E Garber L Saiman 2007 Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis Antimicrob Agents Chemother 51 1085 1088
23. R Gold E Jin H Levison A Isles PC Fleming 1983 Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia J Antimicrob Chemother 12 Suppl A 331 336
24. G Golini G Cazzola R Fontana 2006 Molecular epidemiology and antibiotic susceptibility of Burkholderia cepacia-complex isolates from an Italian cystic fibrosis centre Eur J Clin Microbiol Infect Dis 25 175 180
25. S Nzula P Vandamme JRW Govan 2002 Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex J Antimicrob Chemother 50 265 269
26. E Caraher G Reynolds P Murphy S McClean M Callaghan 2007 Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro Eur J Clin Microbiol Infect Dis 26 213 216
27. MV Cunha SA Sousa JH Leitão LM Moreira PA Videira I Sá-Correia 2004 Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections J Clin Microbiol 42 3052 3058
28. MS St Denis K Ramotar K Vandemheen E Tullis W Ferris F Chan C Lee R Slinger SD Aaron 2007 Infection with Burkholderia cepacia complex bacteria and pulmonary exacerbations of cystic fibrosis Chest 131 1188 1196
29. E Denamur I Matic 2006 Evolution of mutation rates in bacteria Mol Microbiol 60 820 827